{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T11:50:21Z","timestamp":1784029821805,"version":"3.55.0"},"reference-count":33,"publisher":"Impact Journals, LLC","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2021,5,15]]},"DOI":"10.18632\/aging.203003","type":"journal-article","created":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T20:19:42Z","timestamp":1620764382000},"page":"13225-13238","source":"Crossref","is-referenced-by-count":24,"title":["TRIM14 regulates melanoma malignancy via PTEN\/PI3K\/AKT and STAT3 pathways"],"prefix":"10.18632","volume":"13","author":[{"given":"Jiangyan","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Oncology, Jiangjin Central Hospital of Chongqing, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Jiangjin Central Hospital of Chongqing, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Quan","sequence":"additional","affiliation":[{"name":"Department of Oncology, Jiangjin Central Hospital of Chongqing, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debing","family":"Xiang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Jiangjin Central Hospital of Chongqing, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2021,5,11]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.molcel.2019.11.009","article-title":"Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma.","volume":"7","author":"Valiga","year":"2020","journal-title":"Mol Cell"},{"key":"2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1146\/annurev-pathol-052016-100208","article-title":"Signaling and Immune Regulation in Melanoma Development and Responses to Therapy.","volume":"1","author":"Fisher","year":"2017","journal-title":"Annu Rev Pathol"},{"key":"3","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.semcancer.2019.08.001","article-title":"Immune-checkpoint inhibitors for the treatment of metastatic melanoma: a model of cancer immunotherapy.","volume":"5","author":"Quaglino","year":"2019","journal-title":"Semin Cancer Biol"},{"key":"4","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/s41571-019-0204-6","article-title":"Cell-state dynamics and therapeutic resistance in melanoma from the perspective of MITF and IFN\u03b3 pathways.","volume":"1","author":"Flaherty","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"5","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1002\/cam4.1001","article-title":"A systematic review and network meta-analysis of immunotherapy and targeted therapy for advanced melanoma.","volume":"6","author":"de Lima Lopes","year":"2017","journal-title":"Cancer Med"},{"key":"6","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1515\/hsz-2019-0158","article-title":"Emerging RNA-binding roles in the TRIM family of ubiquitin ligases.","volume":"40","author":"Hennig","year":"2019","journal-title":"Biol Chem"},{"key":"7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41389-020-0229-9","article-title":"TRIM11 facilitates chemoresistance in nasopharyngeal carcinoma by activating the \u03b2-catenin\/ABCC9 axis via p62-selective autophagic degradation of Daple.","volume":"9","author":"Sang","year":"2020","journal-title":"Oncogenesis"},{"key":"8","doi-asserted-by":"publisher","first-page":"5491","DOI":"10.1111\/jcmm.15203","article-title":"TRIM23 overexpression is a poor prognostic factor and contributes to carcinogenesis in colorectal cancer.","volume":"2","author":"Tian","year":"2020","journal-title":"J Cell Mol Med"},{"key":"9","first-page":"114","article-title":"TRIM21 overexpression promotes tumor progression by regulating cell proliferation, cell migration and cell senescence in human glioma.","volume":"1","author":"Lu","year":"2020","journal-title":"Am J Cancer Res"},{"key":"10","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41467-019-14190-2","article-title":"TRIM25 promotes the cell survival and growth of hepatocellular carcinoma through targeting Keap1-Nrf2 pathway.","volume":"1","author":"Chen","year":"2020","journal-title":"Nat Commun"},{"key":"11","doi-asserted-by":"publisher","first-page":"7174","DOI":"10.1038\/ncomms8174","article-title":"Activating MET kinase rearrangements in melanoma and Spitz tumours.","volume":"6","author":"Bastian","year":"2015","journal-title":"Nat Commun"},{"key":"12","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1007\/s00432-019-02981-5","article-title":"Heterozygous loss of keratinocyte TRIM16 expression increases melanocytic cell lesions and lymph node metastasis.","volume":"14","author":"Marshall","year":"2019","journal-title":"J Cancer Res Clin Oncol"},{"key":"13","doi-asserted-by":"publisher","first-page":"6696","DOI":"10.1158\/1078-0432.CCR-13-1746","article-title":"BRAF fusions define a distinct molecular subset of melanomas with potential sensitivity to MEK inhibition.","volume":"1","author":"Pao","year":"2013","journal-title":"Clin Cancer Res"},{"key":"14","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/s41418-018-0169-5","article-title":"TRIM17 and TRIM28 antagonistically regulate the ubiquitination and anti-apoptotic activity of BCL2A1.","volume":"2","author":"Aouacheria","year":"2019","journal-title":"Cell Death Differ"},{"key":"15","doi-asserted-by":"publisher","first-page":"42411","DOI":"10.1038\/srep42411","article-title":"TRIM14 regulates cell proliferation and invasion in osteosarcoma via promotion of the AKT signaling pathway.","volume":"7","author":"Kang","year":"2017","journal-title":"Sci Rep"},{"key":"16","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12935-018-0701-1","article-title":"TRIM14 promotes colorectal cancer cell migration and invasion through the SPHK1\/STAT3 pathway.","volume":"1","author":"Wu","year":"2018","journal-title":"Cancer Cell Int"},{"key":"17","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3727\/096504018X15214994641786","article-title":"TRIM14 Promotes Breast Cancer Cell Proliferation by Inhibiting Apoptosis.","volume":"2","author":"Wang","year":"2019","journal-title":"Oncol Res"},{"key":"18","doi-asserted-by":"publisher","first-page":"5403","DOI":"10.1038\/s41388-018-0344-7","article-title":"TRIM14 promotes chemoresistance in gliomas by activating Wnt\/\u03b2-catenin signaling via stabilizing Dvl2.","volume":"3","author":"Zhang","year":"2018","journal-title":"Oncogene"},{"key":"19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13046-019-1070-x","article-title":"Tripartite motif-containing 14 (TRIM14) promotes epithelial-mesenchymal transition via ZEB2 in glioblastoma cells.","volume":"3","author":"Li","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"20","doi-asserted-by":"publisher","first-page":"5725","DOI":"10.2147\/CMAR.S210782","article-title":"TRIM14 promotes cell proliferation and inhibits apoptosis by suppressing PTEN in colorectal cancer.","volume":"1","author":"Wu","year":"2019","journal-title":"Cancer Manag Res"},{"key":"21","doi-asserted-by":"publisher","first-page":"e1007167","DOI":"10.1371\/journal.pgen.1007167","article-title":"Differential roles of the Drosophila EMT-inducing transcription factors Snail and Serpent in driving primary tumour growth.","volume":"1","author":"Casanova","year":"2018","journal-title":"PLoS Genet"},{"key":"22","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.acthis.2016.05.002","article-title":"Ki67, PCNA, and MCM proteins: Markers of proliferation in the diagnosis of breast cancer.","volume":"11","author":"Varga","year":"2016","journal-title":"Acta Histochem"},{"key":"23","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1007\/s00066-018-1356-5","article-title":"Long-term survival of patients after ipilimumab and hypofractionated brain radiotherapy for brain metastases of malignant melanoma: sequence matters.","volume":"19","author":"Mayer","year":"2018","journal-title":"Strahlenther Onkol"},{"key":"24","doi-asserted-by":"publisher","first-page":"3710","DOI":"10.1038\/s41388-018-0640-2","article-title":"Thymine DNA glycosylase as a novel target for melanoma.","volume":"3","author":"Sun","year":"2019","journal-title":"Oncogene"},{"key":"25","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1002\/2211-5463.12682","article-title":"TRIM14 expression is regulated by IRF-1 and IRF-2.","volume":"9","author":"Qiao","year":"2019","journal-title":"FEBS Open Bio"},{"key":"26","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.3892\/or.2018.6750","article-title":"TRIM14 promotes the migration and invasion of gastric cancer by regulating epithelial-to-mesenchymal transition via activation of AKT signaling regulated by miR-195-5p.","volume":"4","author":"Wei","year":"2018","journal-title":"Oncol Rep"},{"key":"27","doi-asserted-by":"publisher","first-page":"39692","DOI":"10.1038\/srep39692","article-title":"TRIM14 is a Putative Tumor Suppressor and Regulator of Innate Immune Response in Non-Small Cell Lung Cancer.","volume":"7","author":"Tsao","year":"2017","journal-title":"Sci Rep"},{"key":"28","doi-asserted-by":"publisher","first-page":"840","DOI":"10.3390\/ijms20040840","article-title":"Targeting Tumor Microenvironment for Cancer Therapy.","volume":"2","author":"Fernandes","year":"2019","journal-title":"Int J Mol Sci"},{"key":"29","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.semcancer.2019.06.002","article-title":"Akt in cancer: Mediator and more.","volume":"5","author":"Munirajan","year":"2019","journal-title":"Semin Cancer Biol"},{"key":"30","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s12935-019-0998-4","article-title":"TRIM27 promotes the development of esophagus cancer via regulating PTEN\/AKT signaling pathway.","volume":"1","author":"Zhuang","year":"2019","journal-title":"Cancer Cell Int"},{"key":"31","doi-asserted-by":"publisher","first-page":"108960","DOI":"10.1016\/j.cbi.2020.108960","article-title":"Knockdown of TRIM47 inhibits breast cancer tumorigenesis and progression through the inactivation of PI3K\/Akt pathway.","volume":"31","author":"Lu","year":"2020","journal-title":"Chem Biol Interact"},{"key":"32","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer.","volume":"1","author":"Grandis","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"33","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.bbrc.2019.10.127","article-title":"Tripartite motif containing 14: An oncogene in papillary thyroid carcinoma.","volume":"52","author":"Sun","year":"2020","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.203003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T17:28:50Z","timestamp":1625765330000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.203003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,11]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,5,15]]}},"alternative-id":["203003","33982666"],"URL":"https:\/\/doi.org\/10.18632\/aging.203003","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,11]]}}}